Genentech Research To Be Headed By Stanford Scientist Scheller
Executive Summary
Genentech has chosen Stanford scientist Richard Scheller, PhD, to succeed Dennis Henner, PhD, as head of research.
You may also be interested in...
Genentech Brings Marketing Back To Senior Management: Potter To COO
Genentech is bringing big pharma sales and marketing expertise back into its senior management structure with the appointment of former Bristol-Myers Squibb exec Myrtle Potter as chief operating officer and exec VP-commercial operations.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials